Biogen sets $55K annual price tag on ...

Biogen sets $55K annual price tag on new MS drug

There are 1 comment on the Business Journal story from Apr 1, 2013, titled Biogen sets $55K annual price tag on new MS drug. In it, Business Journal reports that:

Two days after the U.S. approval of a new multiple sclerosis drug at least one analyst expects to eventually hit $6 billion in annual sales, Biogen Idec announced a $54,900 annual price per patient for Tecfidera.

Join the discussion below, or Read more at Business Journal.

Chris

Boston, MA

#1 Apr 1, 2013
Robbery. 14 year patent protection should have kept this drug around 20k a year. All MS drugs are overpriced for their efficacy. How much will the upcoming drugs that may reverse the damage cost? 150k 200k a year? Where is the limit? I believe Pharma should be paid, but this is robbery. Just how much did it cost them not to have MS, Lupus, RA, etc? So glad the government is trying to protect me from guns and gay marriage instead of things I can't provide my own protection against.

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Health Discussions

Title Updated Last By Comments
News Halton Catholic students stage walkouts to prot... 7 hr Good on em 1
paddled hard at school (Aug '17) 7 hr badd bobb 3
what's the cause of swollen epididymis? 12 hr Imrckhd68 3
Head swap 15 hr Imrckhd68 1
News After Baltz Firing, CARTI Issues Statement 20 hr Regina C 8
News 'The screaming is not going to stop': school co... Fri cant trust Trustees 2
News Hepatitis A Outbreak: Victims File a Lawsuit Ag... Fri Suxazz 2
watching wife get pregnant by another man (Jan '17) Apr 18 mikeae102754_att_net 76